Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (551-560 of 706) with videos related to

Pageof 71
Sort By:
Plos One|December 25, 2013
Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and genderDebra L Foley, Andrew Mackinnon, Gerald F Watts, et al.
Heart, Lung & Circulation|May 21, 2019
Status of PCSK9 Monoclonal Antibodies in AustraliaDaniel J Scherer, Adam J Nelson, Richard O'Brien, et al.
BMJ Open|October 25, 2017
Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisonsDiane E Arnold-Reed, Tom Brett, Lakkhina Troeung, et al.
Cardiovascular Diabetology|November 23, 2011
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialRussell Scott, Mark Donoghoe, Gerald F Watts, et al.
The Australian and New Zealand Journal of Psychiatry|January 15, 2015
Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sampleDebra L Foley, Andrew Mackinnon, Vera A Morgan, et al.
Atherosclerosis|March 16, 2020
An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemiaJing Pang, Arun Abraham, Cristian Vargas-García, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 29, 2015
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic StudyJan Borén, Gerald F Watts, Martin Adiels, et al.
Atherosclerosis|May 18, 2019
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemiaLeopoldo Pérez de Isla, Kausik K Ray, Gerald F Watts, et al.
Circulation. Genomic and Precision Medicine|April 12, 2023
Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on InvestmentClara Marquina, Jedidiah Morton, Tom Brett, et al.
AAPS Pharmscitech|August 30, 2014
Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetesArmin Mooranian, Rebecca Negrulj, Hesham S Al-Sallami, et al.
Pageof 71

Showing results (551-560 of 706) with videos related to

Sort By:
Pageof 71
Plos One|December 25, 2013
Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and genderDebra L Foley, Andrew Mackinnon, Gerald F Watts, et al.
Heart, Lung & Circulation|May 21, 2019
Status of PCSK9 Monoclonal Antibodies in AustraliaDaniel J Scherer, Adam J Nelson, Richard O'Brien, et al.
BMJ Open|October 25, 2017
Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisonsDiane E Arnold-Reed, Tom Brett, Lakkhina Troeung, et al.
Cardiovascular Diabetology|November 23, 2011
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialRussell Scott, Mark Donoghoe, Gerald F Watts, et al.
The Australian and New Zealand Journal of Psychiatry|January 15, 2015
Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sampleDebra L Foley, Andrew Mackinnon, Vera A Morgan, et al.
Atherosclerosis|March 16, 2020
An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemiaJing Pang, Arun Abraham, Cristian Vargas-García, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 29, 2015
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic StudyJan Borén, Gerald F Watts, Martin Adiels, et al.
Atherosclerosis|May 18, 2019
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemiaLeopoldo Pérez de Isla, Kausik K Ray, Gerald F Watts, et al.
Circulation. Genomic and Precision Medicine|April 12, 2023
Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on InvestmentClara Marquina, Jedidiah Morton, Tom Brett, et al.
AAPS Pharmscitech|August 30, 2014
Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetesArmin Mooranian, Rebecca Negrulj, Hesham S Al-Sallami, et al.
Pageof 71